Upgrade to SI Premium - Free Trial

Exact Sciences (EXAS) Tops Q3 EPS by 10c, FY Revenue Guidance Misses at Mid-Point

October 29, 2019 4:11 PM
Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.31), $0.10 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles